Reviva Pharmaceuticals Holdings (RVPH)
$1.12
Performance
- $1.02$1.28$1.12
9.38%
Downside
Day's Volatility :20.7%
Upside
12.5%
- $0.60$6.80$1.12
46.43%
Downside
52 Weeks Volatility :91.18%
Upside
83.53%
Returns
| Period | Reviva Pharmaceuticals Holdings | Index (Russel 2000) |
|---|---|---|
3 Months | -25.33% | 0.0% |
6 Months | -64.33% | 0.0% |
1 Year | -78.95% | 0.0% |
3 Years | -73.01% | -21.1% |
Highlights
Market Capitalization | 43.0M |
Book Value | - $0.2 |
Earnings Per Share (EPS) | -1.32 |
Wall Street Target Price | 14.6 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -233.95% |
Return On Equity TTM | -1795.06% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -10.1M |
Diluted Eps TTM | -1.32 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.96 |
EPS Estimate Next Year | -0.9 |
EPS Estimate Current Quarter | -0.29 |
EPS Estimate Next Quarter | -0.29 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 1203.57%
Technicals Summary
Sell
Neutral
Buy
Reviva Pharmaceuticals Holdings is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Reviva Pharmaceuticals Holdings | 62.44% | -64.33% | -78.95% | -73.01% | -86.14% |
 Regeneron Pharmaceuticals, Inc. | 0.53% | 20.61% | 40.93% | 82.08% | 313.49% |
 Novo Nordisk A/s | 2.31% | 2.37% | 41.89% | 174.22% | 452.16% |
 Alnylam Pharmaceuticals, Inc. | -2.2% | 76.34% | 35.57% | 40.87% | 212.74% |
 Vertex Pharmaceuticals Incorporated | 2.37% | 14.89% | 38.0% | 148.92% | 173.61% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Reviva Pharmaceuticals Holdings | NA | NA | NA | -0.96 | -17.95 | -2.34 | NA | -0.2 |
Regeneron Pharmaceuticals, Inc. | 30.21 | 30.21 | 1.55 | 45.05 | 0.17 | 0.08 | NA | 261.41 |
Novo Nordisk A/s | 45.38 | 45.38 | 2.06 | 3.41 | 0.89 | 0.23 | 0.01 | 25.24 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.55 | -15.01 | 0.02 | NA | -0.02 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 0.58 | 0.32 | -0.03 | 0.13 | NA | 57.26 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Reviva Pharmaceuticals Holdings | Buy | $43.0M | -86.14% | NA | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $125.3B | 313.49% | 30.21 | 32.04% |
Novo Nordisk A/s | Buy | $576.2B | 452.16% | 45.38 | 34.84% |
Alnylam Pharmaceuticals, Inc. | Buy | $33.6B | 212.74% | NA | -3.11% |
Vertex Pharmaceuticals Incorporated | Buy | $123.5B | 173.61% | 32.84 | -4.74% |
Insights on Reviva Pharmaceuticals Holdings
Vs NVO
In the last 1 year, Novo Nordisk A/s has given 41.9% return, outperforming this stock by 120.8%
Vs NVO
In the last 3 years, Novo Nordisk A/s has given 174.2% return, outperforming this stock by 247.2%
Institutional Holdings
Woodline Partners LP
4.81%Millennium Management LLC
3.75%Vanguard Group Inc
3.10%Schonfeld Strategic Advisors LLC
3.06%Parkman Healthcare Partners LLC
1.52%Sabby Management LLC
0.72%
Company Information
reviva pharmaceuticals is a pharmaceuticals company located in 5941 optical ct, san jose, california, united states.
Organization | Reviva Pharmaceuticals Holdings |
Employees | 15 |
CEO | Dr. Laxminarayan Bhat Ph.D. |
Industry | Miscellaneous |
Discover More
A Spac I Acquisition Corp
$1.12
-13.85%
Keyarch Acquisition Corp
$1.12
-13.85%
Connexa Sports Technologies Inc
$1.12
-13.85%
Us Value Etf
$1.12
-13.85%
First Wave Biopharma Inc
$1.12
-13.85%
Global X Msci Next Emerging
$1.12
-13.85%
Fat Projects Acquisition Corp
$1.12
-13.85%
Capital Link Global Fintech
$1.12
-13.85%
Applied Uv Inc
$1.12
-13.85%